181 related articles for article (PubMed ID: 19996358)
1. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
Ting SC; Crooks SW; South G
J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
[TBL] [Abstract][Full Text] [Related]
2. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination.
Menon B; Gurnani M; Aggarwal B
Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444
[TBL] [Abstract][Full Text] [Related]
4. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
Schembri S; Morant S; Winter JH; MacDonald TM
Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
[TBL] [Abstract][Full Text] [Related]
5. [Effects of vaccination against influenza on progression of chronic obstructive pulmonary diseases].
Prozorova GG; Simonaĭtes SV; Burlachuk VT
Ter Arkh; 2005; 77(1):59-62. PubMed ID: 15759457
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination among Canadians with chronic respiratory disease.
Vozoris NT; Lougheed MD
Respir Med; 2009 Jan; 103(1):50-8. PubMed ID: 18818066
[TBL] [Abstract][Full Text] [Related]
8. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
[TBL] [Abstract][Full Text] [Related]
9. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary disease].
Montserrat-Capdevila J; Godoy P; Marsal JR; Cruz I; Solanes M
Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):70-5. PubMed ID: 23582192
[TBL] [Abstract][Full Text] [Related]
11. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease.
Vila-Córcoles A; Ochoa O; de Diego C; Valdivieso A; Herreros I; Bobé F; Alvarez M; Juárez M; Guinea I; Ansa X; Saún N
Int J Clin Pract; 2008 Jan; 62(1):10-7. PubMed ID: 17573840
[TBL] [Abstract][Full Text] [Related]
12. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
Drescher GS; Carnathan BJ; Imus S; Colice GL
Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease.
Anar C; Bicmen C; Yapicioglu S; Unsal I; Halilcolar H; Yilmaz U
New Microbiol; 2010 Apr; 33(2):117-27. PubMed ID: 20518273
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.
Garrastazu R; García-Rivero JL; Ruiz M; Helguera JM; Arenal S; Bonnardeux C; León C; Llorca J; Santibañez M
Arch Bronconeumol; 2016 Feb; 52(2):88-95. PubMed ID: 26526292
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.
Leavitt BJ; Ross CS; Spence B; Surgenor SD; Olmstead EM; Clough RA; Charlesworth DC; Kramer RS; O'Connor GT;
Circulation; 2006 Jul; 114(1 Suppl):I430-4. PubMed ID: 16820614
[TBL] [Abstract][Full Text] [Related]
16. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of multidisciplinary care in chronic obstructive pulmonary disease patients at the Central Chest Institute of Thailand.
Panjapornpon K; Tanont S
J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S24-30. PubMed ID: 23130471
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
19. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
Niewoehner DE
Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
[TBL] [Abstract][Full Text] [Related]
20. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
